557 related articles for article (PubMed ID: 25344439)
1. Continuous production of fenofibrate solid lipid nanoparticles by hot-melt extrusion technology: a systematic study based on a quality by design approach.
Patil H; Feng X; Ye X; Majumdar S; Repka MA
AAPS J; 2015 Jan; 17(1):194-205. PubMed ID: 25344439
[TBL] [Abstract][Full Text] [Related]
2. Continuous manufacturing of solid lipid nanoparticles by hot melt extrusion.
Patil H; Kulkarni V; Majumdar S; Repka MA
Int J Pharm; 2014 Aug; 471(1-2):153-6. PubMed ID: 24853459
[TBL] [Abstract][Full Text] [Related]
3. Formulation of topical ibuprofen solid lipid nanoparticle (SLN) gel using hot melt extrusion technique (HME) and determining its anti-inflammatory strength.
Bagde A; Patel K; Kutlehria S; Chowdhury N; Singh M
Drug Deliv Transl Res; 2019 Aug; 9(4):816-827. PubMed ID: 30924025
[TBL] [Abstract][Full Text] [Related]
4. Conjugation of Hot-Melt Extrusion with High-Pressure Homogenization: a Novel Method of Continuously Preparing Nanocrystal Solid Dispersions.
Ye X; Patil H; Feng X; Tiwari RV; Lu J; Gryczke A; Kolter K; Langley N; Majumdar S; Neupane D; Mishra SR; Repka MA
AAPS PharmSciTech; 2016 Feb; 17(1):78-88. PubMed ID: 26283197
[TBL] [Abstract][Full Text] [Related]
5. Hot melt extrusion technology for improved dissolution, solubility and "spring-parachute" processes of amorphous self-micellizing solid dispersions containing BCS II drugs indomethacin and fenofibrate: Profiles and mechanisms.
Shi NQ; Wang SR; Zhang Y; Huo JS; Wang LN; Cai JH; Li ZQ; Xiang B; Qi XR
Eur J Pharm Sci; 2019 Mar; 130():78-90. PubMed ID: 30684657
[TBL] [Abstract][Full Text] [Related]
6. Stabilization of fenofibrate in low molecular weight hydroxypropylcellulose matrices produced by hot-melt extrusion.
Deng W; Majumdar S; Singh A; Shah S; Mohammed NN; Jo S; Pinto E; Tewari D; Durig T; Repka MA
Drug Dev Ind Pharm; 2013 Feb; 39(2):290-8. PubMed ID: 22524504
[TBL] [Abstract][Full Text] [Related]
7. Optimization of a PGSS (particles from gas saturated solutions) process for a fenofibrate lipid-based solid dispersion formulation.
Pestieau A; Krier F; Lebrun P; Brouwers A; Streel B; Evrard B
Int J Pharm; 2015 May; 485(1-2):295-305. PubMed ID: 25796121
[TBL] [Abstract][Full Text] [Related]
8. Formulation and processing of solid self-emulsifying drug delivery systems (HME S-SEDDS): A single-step manufacturing process via hot-melt extrusion technology through response surface methodology.
Raman Kallakunta V; Dudhipala N; Nyavanandi D; Sarabu S; Yadav Janga K; Ajjarapu S; Bandari S; Repka MA
Int J Pharm; 2023 Jun; 641():123055. PubMed ID: 37207857
[TBL] [Abstract][Full Text] [Related]
9. Study on the release of fenofibrate nanosuspension in vitro and its correlation with in situ intestinal and in vivo absorption kinetics in rats.
Xu Y; Wang Y; Li XM; Huang Q; Chen W; Liu R; Chen B; Wei P
Drug Dev Ind Pharm; 2014 Jul; 40(7):972-9. PubMed ID: 23692349
[TBL] [Abstract][Full Text] [Related]
10. Development of an Ointment Formulation Using Hot-Melt Extrusion Technology.
Bhagurkar AM; Angamuthu M; Patil H; Tiwari RV; Maurya A; Hashemnejad SM; Kundu S; Murthy SN; Repka MA
AAPS PharmSciTech; 2016 Feb; 17(1):158-66. PubMed ID: 26628438
[TBL] [Abstract][Full Text] [Related]
11. Preparation and in vitro/in vivo evaluation of fenofibrate nanocrystals.
Zuo B; Sun Y; Li H; Liu X; Zhai Y; Sun J; He Z
Int J Pharm; 2013 Oct; 455(1-2):267-75. PubMed ID: 23876497
[TBL] [Abstract][Full Text] [Related]
12. The in vitro and in vivo evaluation of fenofibrate with a self- microemulsifying formulation.
Xiumin LI; Man GE; Minzi LU; Yinghua J; Dongqin Q
Curr Drug Deliv; 2015; 12(3):308-13. PubMed ID: 26054534
[TBL] [Abstract][Full Text] [Related]
13. Formulation of Topical Flurbiprofen Solid Lipid Nanoparticle Gel Formulation Using Hot Melt Extrusion Technique.
Bagde A; Kouagou E; Singh M
AAPS PharmSciTech; 2022 Sep; 23(7):257. PubMed ID: 36114430
[TBL] [Abstract][Full Text] [Related]
14. [Application research of hot-melt extrusion in preparation of solid dispersion].
Chen MW; Chen WR; Chen TK; Chen RE; Wang YT
Yao Xue Xue Bao; 2012 Feb; 47(2):163-7. PubMed ID: 22512025
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evaluation of a self-microemulsifying drug delivery system for the poorly soluble drug fenofibrate.
Cho YD; Park YJ
Arch Pharm Res; 2014 Feb; 37(2):193-203. PubMed ID: 23754165
[TBL] [Abstract][Full Text] [Related]
16. Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance.
Fule R; Dhamecha D; Maniruzzaman M; Khale A; Amin P
Int J Pharm; 2015 Dec; 496(1):137-56. PubMed ID: 26471056
[TBL] [Abstract][Full Text] [Related]
17. Dissolution improvement of solid self-emulsifying drug delivery systems of fenofibrate using an inorganic high surface adsorption material.
Shazly G; Mohsin K
Acta Pharm; 2015 Mar; 65(1):29-42. PubMed ID: 25781702
[TBL] [Abstract][Full Text] [Related]
18. Hot-Melt Extrusion: a Roadmap for Product Development.
Simões MF; Pinto RMA; Simões S
AAPS PharmSciTech; 2021 Jun; 22(5):184. PubMed ID: 34142250
[TBL] [Abstract][Full Text] [Related]
19. Optimizing SLN and NLC by 2(2) full factorial design: effect of homogenization technique.
Severino P; Santana MH; Souto EB
Mater Sci Eng C Mater Biol Appl; 2012 Aug; 32(6):1375-9. PubMed ID: 24364934
[TBL] [Abstract][Full Text] [Related]
20. A quality by design approach to develop topical creams via hot-melt extrusion technology.
Mendonsa NS; Pradhan A; Sharma P; Prado RMB; Murthy SN; Kundu S; Repka MA
Eur J Pharm Sci; 2019 Aug; 136():104948. PubMed ID: 31173868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
